T cell precursor frequency differentially affects CTL responses under different immune conditions

Biochemical and Biophysical Research Communications

Volumn 367, Issue 2, 2008, Pages 427-434

  Ye, Zhenmin ^a   Ahmed, Khawaja Ashfaque ^a   Huang, Junqiong ^a   Xie, Yufeng ^a   Munegowda, Manjunatha Ankathatti ^a   Xiang, Jim ^a  

^a SASKATCHEWAN CANCER AGENCY   (Canada)

Author keywords

CD4+; CD8+; CTL response; T cell precursors; Transgenic RIP mOVA mice

Indexed keywords

OVALBUMIN;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STEM CELL; T LYMPHOCYTE; TRANSGENE; VACCINATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; IMMUNITY, NATURAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

MUS;

EID: 38349056466     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.149     Document Type: Article

References (24)

1. + T-cell responses. Curr. Biol. 4 (1994) 499-505
2. + T cell help. J. Exp. Med. 186 (1997) 65-70
3. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18 (2000) 275-308
4. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., and Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393 (1998) 478-480
5. Kurts C., Heath W.R., Kosaka H., Miller J.F., and Carbone F.R. The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J. Exp. Med. 188 (1998) 415-420
6. Piechocki M.P., Ho Y.S., Pilon S., and Wei W.Z. Human ErbB-2 (Her-2) transgenic mice: a model system for testing Her-2 based vaccines. J. Immunol. 171 (2003) 5787-5794
7. Saha A., Chatterjee S.K., Foon K.A., Celis E., and Bhattacharya-Chatterjee M. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. Cancer Res. 67 (2007) 2881-2892
8. Mintern J.D., Davey G.M., Belz G.T., Carbone F.R., and Heath W.R. Cutting edge: precursor frequency affects the helper dependence of cytotoxic T cells. J. Immunol. 168 (2002) 977-980
9. + T helper-antigen-presenting cells. J. Immunol. 174 (2005) 7497-7505
10. Shi M., Hao S., Chan T., and Xiang J. CD4(+) T cells stimulate memory CD8(+) T cell expansion via acquired pMHC I complexes and costimulatory molecules, and IL-2 secretion. J. Leukoc. Biol. 80 (2006) 1354-1363
11. Moore A.C., Gallimore A., Draper S.J., Watkins K.R., Gilbert S.C., and Hill A.V. Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J. Immunol. 175 (2005) 7264-7273
12. Garcia Z., Pradelli E., Celli S., Beuneu H., Simon A., and Bousso P. Competition for antigen determines the stability of T cell-dendritic cell interactions during clonal expansion. Proc. Natl. Acad. Sci. USA 104 (2007) 4553-4558
13. Blair D.A., and Lefrancois L. Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells. Proc. Natl. Acad. Sci. USA 104 (2007) 15045-15050
14. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2 (2002) 389-400
15. Sobek V., Balkow S., Korner H., and Simon M.M. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes. Eur. J. Immunol. 32 (2002) 2490-2499
16. + T cell lineage commitment. Nat. Immunol. 6 (2005) 793-799
17. + T cells. J. Immunol. 176 (2006) 3028-3036
18. Ford M.L., Koehn B.H., Wagener M.E., Jiang W., Gangappa S., Pearson T.C., and Larsen C.P. Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J. Exp. Med. 204 (2007) 299-309
19. + T lymphocytes. Nature 421 (2003) 852-856
20. Northrop J.K., Thomas R.M., Wells A.D., and Shen H. Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells. J. Immunol. 177 (2006) 1062-1069
21. Steinaa L., Rasmussen P.B., Wegener A.M., Sonderbye L., Leach D.R., Rygaard J., Mouritsen S., and Gautam A.M. Linked foreign T-cell help activates self-reactive CTL and inhibits tumor growth. J. Immunol. 175 (2005) 329-334
22. + lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice. J. Immunol. 161 (1998) 5500-5506
23. Huang H., Hao S., Li F., Ye Z., Yang J., and Xiang J. CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes. Immunology 120 (2007) 148-159
24. Turner M.S., Cohen P.A., and Finn O.J. Lack of effective MUC1 tumor antigen-specific immunity in MUC1-transgenic mice results from a Th/T regulatory cell imbalance that can be corrected by adoptive transfer of wild-type Th cells. J. Immunol. 178 (2007) 2787-2793